SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950159-13-000448
Filing Date
2013-07-05
Accepted
2013-07-05 17:12:11
Documents
13
Period of Report
2013-06-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 TENGION, INC. FORM 8-K tengion8k.htm 8-K 54958
2 EXHIBIT 4.1 ex4-1.htm EX-4.1 193151
3 EXHIBIT 4.2 ex4-2.htm EX-4.2 216588
4 EXHIBIT 4.3 ex4-3.htm EX-4.3 216160
5 EXHIBIT 10.1 ex10-1.htm EX-10.1 336209
6 EXHIBIT 10.2 ex10-2.htm EX-10.2 355537
7 EXHIBIT 10.3 ex10-3.htm EX-10.3 129976
8 EXHIBIT 10.4 ex10-4.htm EX-10.4 169456
9 EXHIBIT 10.5 ex10-5.htm EX-10.5 118292
10 EXHIBIT 10.6 ex10-6.htm EX-10.6 186407
11 EXHIBIT 10.7 ex10-7.htm EX-10.7 38469
12 EXHIBIT 99.1 ex99-1.htm EX-99.1 17683
13 tengionred.jpg GRAPHIC 5677
  Complete submission text file 0000950159-13-000448.txt   2042172
Mailing Address 3929 WESTPOINT BLVD. SUITE G WINSTON-SALEM NC 27103
Business Address 3929 WESTPOINT BLVD. SUITE G WINSTON-SALEM NC 27103 336-722-5855
TENGION INC (Filer) CIK: 0001296391 (see all company filings)

IRS No.: 200214813 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34688 | Film No.: 13955883
SIC: 2836 Biological Products, (No Diagnostic Substances)